STATE STREET CORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$33,795,845
-67.0%
2,092,622
-15.2%
0.00%
-60.0%
Q2 2023$102,365,311
-38.6%
2,466,634
-11.0%
0.01%
-44.4%
Q1 2023$166,622,782
-49.2%
2,770,608
-38.1%
0.01%
-10.0%
Q4 2022$328,263,256
+64.6%
4,475,300
+70.5%
0.01%
-23.1%
Q3 2022$199,435,000
+25.4%
2,624,838
+14.7%
0.01%
+30.0%
Q2 2022$159,057,000
-23.2%
2,288,595
-8.4%
0.01%0.0%
Q1 2022$207,006,000
+10.7%
2,498,569
+0.4%
0.01%
+11.1%
Q4 2021$186,934,000
-27.0%
2,489,794
+13.0%
0.01%
-35.7%
Q3 2021$255,986,000
-48.7%
2,203,547
-2.0%
0.01%
-46.2%
Q2 2021$498,781,000
+84.3%
2,248,585
+9.8%
0.03%
+62.5%
Q1 2021$270,691,000
-19.1%
2,047,896
+5.9%
0.02%
-20.0%
Q4 2020$334,777,000
+161.1%
1,934,681
+68.0%
0.02%
+122.2%
Q3 2020$128,205,000
+98.9%
1,151,780
+5.9%
0.01%
+80.0%
Q2 2020$64,472,000
-45.1%
1,087,223
-37.6%
0.01%
-50.0%
Q1 2020$117,346,000
-16.5%
1,742,591
+4.4%
0.01%0.0%
Q4 2019$140,614,000
+16.4%
1,668,610
+3.3%
0.01%
+11.1%
Q3 2019$120,808,000
+21.6%
1,615,508
+2.8%
0.01%
+28.6%
Q2 2019$99,320,000
+52.9%
1,570,771
+16.5%
0.01%
+40.0%
Q1 2019$64,964,000
+51.0%
1,348,637
+4.9%
0.01%
+25.0%
Q4 2018$43,027,000
-39.0%
1,285,146
-4.5%
0.00%
-20.0%
Q3 2018$70,549,000
+70.5%
1,346,384
+1.9%
0.01%
+66.7%
Q2 2018$41,369,000
+70.9%
1,321,727
+19.1%
0.00%
+50.0%
Q1 2018$24,201,000
+5.8%
1,110,214
-1.9%
0.00%0.0%
Q4 2017$22,864,000
+6.7%
1,131,968
+4.9%
0.00%0.0%
Q3 2017$21,425,000
+14.4%
1,079,228
-0.3%
0.00%0.0%
Q2 2017$18,728,000
+149.9%
1,082,589
+17.0%
0.00%
+100.0%
Q1 2017$7,494,000
+11.0%
924,947
+7.5%
0.00%0.0%
Q4 2016$6,750,000
-8.5%
860,129
-0.4%
0.00%0.0%
Q3 2016$7,377,000
-19.1%
863,764
+10.6%
0.00%0.0%
Q2 2016$9,117,000
+414.2%
781,171
+537.5%
0.00%
Q1 2016$1,773,000
-9.0%
122,539
+40.5%
0.00%
Q4 2015$1,949,00087,2160.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2019
NameSharesValueWeighting ↓
StepStone Group LP 115,479$7,302,00011.05%
HARTLINE INVESTMENT CORP/ 335,585$21,219,0005.07%
Darsana Capital Partners LP 1,500,000$94,845,0003.08%
Rhenman & Partners Asset Management AB 365,899$23,136,0002.55%
COURAGE CAPITAL MANAGEMENT LLC 20,000$1,265,0002.15%
Taylor Frigon Capital Management LLC 46,599$2,946,0002.04%
Granite Investment Partners, LLC 411,659$26,029,0001.40%
Nicholas Investment Partners, LP 146,106$9,238,0000.85%
Baillie Gifford 8,829,449$558,287,0000.59%
Cortina Asset Management, LLC 141,352$8,938,0000.55%
View complete list of NOVOCURE LTD shareholders